StimLabs rolls out new allograft product Enverse for wound care
US-based regenerative technologies company StimLabs has announced the commercialisation of its new placental membrane-based product, dubbed Enverse. Enverse is a translucent dehydrated complete human placental membrane (dCHPM) allograft